A Phase 1, Single-center, Double-blind, Randomized, Placebo-controlled Clinical Trial to Evaluate the Safety and Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Administrations of TNP-2092 Capsules in Combination With Rabeprazole Sodi
Unknown Phase 1 NCT06337604
Study Description
A phase 1, single-center, double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and tolerability, pharmacokinetics, and preliminary efficacy of multiple administrations of TNP-2092 Capsules in combination with Rabeprazole Sodium Enteric-coated Tablets in asymptomatic healthy subjects with Helicobacter pylori infection
Study Details
- Registry ID:
- NCT06337604
- Conditions:
- Helicobacter Pylori Infection
- Phase:
- Phase 1
- Target Enrollment:
- 20 participants
- Start Date:
- Age Range:
- 18–50 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
The First Hospital of Jilin University
Changchun, Jilin, China
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.